Nigeria case study

Nigeria accounts for more than 25% of the world’s malaria cases and malaria-related deaths — more than any other country.

We applied an Optima Malaria model to estimate the allocation of Nigeria’s current (estimated 2015) spending plus an additional investment by the World Bank of US$300 million that would minimize disability-adjusted life years (DALYs). The study considered funding allocations across Nigeria’s six geopolitical regions, as well as seven interventions:

  • Long lasting insecticide treated nets (LLINs);
  • Indoor residual spraying (IRS);
  • Intermittent presumptive treatment during pregnancy (IPTp);
  • Seasonal mass chemoprevention in children (SMC);
  • Larval source management (LSM);
  • Mass drug administration (MDA); and
  • Behavioural change communication (BCC).

We found that:

  • Optimizing continued estimated 2015 spending + an additional US$300 million investment could avert 119,883 deaths (24%), as well as 1.4 million cases of malaria.
  • Treatment and LLINs are priorities to reduce mortality and incidence respectively.
  • IPTp and BCC are cheap and effective and should be funded.
  • Additional funding should be geographically prioritized to the northern regions.

Visit Optima Publications for more detailed information.